Truist Financial analyst Nicole Germino maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today and set a price target of ...

Sangamo Therapeutics Inc (SGMO) stock saw a decline, ending the day at $1.09 which represents a decrease of $-0.01 or -0.91% from the prior close of $1.1. The stock opened at $1.1 and touched a low of ...

Truist analyst Nicole Germino lowered the firm’s price target on Sangamo (SGMO) to $5 from $7 and keeps a Buy rating on the shares. The firm ...

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sangamo Therapeutics, Inc. ("Sangamo" or the "Company") (NASDAQ:SGMO). Such ...

As of January 13 at 1:06:25 p.m. EST. Market Open.

As of 9:43:12 AM EST. Market Open.

After hours: 7:57:31 pm GMT-5 ...

After hours: January 21 at 6:57:18 p.m. EST ...

Truist Securities adjusted its outlook for Sangamo BioSciences, reducing the price target on the company's shares to $5 from ...

Security Information and Event Management (SIEM) systems are now a critical component of enterprise security. Learn more from Smarttech247 about how its VisionX + Splunk solution can help secure ...